⌘K

Login Start Free

Home/Filings/4/0000905148-25-000727

4//SEC Filing

Gamelin Erick 4

Accession 0000905148-25-000727

CIK 0001781174other

View on SEC.gov Company Profile

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 4:54 PM ET

Size

4.4 KB

Accession

0000905148-25-000727

Insider Transaction Report

Form 4

Period: 2025-02-14

Acrivon Therapeutics, Inc.ACRV

Chief Development Officer

Transactions

Tax Payment
Common Stock
2025-02-14$5.42/sh−469$2,542→ 16,492 total

Footnotes (1)

[F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Documents

1 file

4
form4.xmlPrimary

Issuer

Acrivon Therapeutics, Inc.

CIK 0001781174

Entity typeother

Related Parties

1

filerCIK 0001950551

Filing Metadata

Form type: 4
Filed: Feb 18, 7:00 PM ET
Accepted: Feb 19, 4:54 PM ET
Size: 4.4 KB

View on SEC.gov